Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Exploring brainstem function in multiple sclerosis by combining brainstem reflexes, evoked potentials, clinical and MRI investigations.
Metabolic and safety issues for multiple sclerosis pharmacotherapy - opportunities for personalised medicine.
OnabotulinumtoxinA (Botox(®)): A Review of its Use in the Treatment of Urinary Incontinence in Patients with Multiple Sclerosis or Subcervical Spinal Cord Injury.
siRNA knockdown of ADAM-10, but not ADAM-17, significantly reduces fractalkine shedding following pro-inflammatory cytokine treatment in a human adult brain endothelial cell line.
AP-1 Mediated Transcriptional Repression of Matrix Metalloproteinase-9 by Recruitment of Histone Deacetylase 1 in Response to Interferon β.
Training in MS: influence of two different endurance training protocols (aquatic versus overland) on cytokine and neurotrophin concentrations during three week randomized controlled trial.
The Puerto Rico study for the prevalence of Multiple Sclerosis.
Merck KGaA to try again to get approval for MS pill cladribine
Venocentric Lesions: An MRI Marker of MS?
Comparing Two Deep Brain Stimulation Leads to One in Refractory Tremor.
Editorial: new avenues of research on multiple sclerosis from the perspective of chronic cerebrospinal venous insufficiency paradigm.
Imaging of the spine at 3 tesla.
Genotype-phenotype correlation for non-HLA disease associated risk alleles in multiple sclerosis.
No MRI evidence of cortical lesions in neuromyelitis optica.
Role of Venoplasty for Treatment of Multiple Sclerosis: Value of Open-label Studies and Surrogate Treatment Outcomes.
White matter atrophy and cognitive dysfunctions in neuromyelitis optica.
Extensive molluscum contagiosum virus infection in a young adult receiving fingolimod.
Multiple sclerosis: Five new things.
Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis.
Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis.
Multiple sclerosis.
Coping strategies and mood profiles in patients with multiple sclerosis.
Fingolimod-Associated Peripheral Vascular Adverse Effects.
The role of endogenous antiradical protective system in multiple sclerosis.
A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis.
Pages
« first
‹ previous
…
216
217
218
219
220
221
222
223
224
…
next ›
last »